Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4-5
|
pubmed:dateCreated |
1989-7-10
|
pubmed:abstractText |
We have conducted a modified double-blind study on the effect of human chorionic gonadotropin (hCG), gonadotropin releasing hormone (GnRH) and placebo on bilateral and unilateral maldescended testes. One hundred and fifty-five boys with bilateral and 88 boys with unilateral cryptorchidism fulfilled the inclusion criteria and completed the treatment protocol. The boys were between 1 and 13 years of age. hCG was administered as intramuscular injections twice weekly for 3 weeks. GnRH and placebo were given intranasally. hCG was superior to GnRH and placebo in the treatment of bilateral maldescended testes (p = 0.0009). Both testes descended in 25% of the boys following treatment with hCG, and improvement in the position of the testes was obtained in a further 25% of the cases. hCG administration resulted in complete testicular descent in 14% of boys with unilateral cryptorchidism compared with 3 and 0% after placebo and GnRH, respectively (p = 0.07). The testis had moved to a more distal position in 46% of the boys treated with hCG. There was no significant difference between the treatment groups with regard to age or initial position of the testes. We conclude that a success rate of 25% justifies the use of hCG in the treatment of maldescended testes, whereas the study did not support a general use of GnRH administered intranasally.
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0301-0163
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
30
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
N
|
pubmed:pagination |
187-92
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:2907896-Administration, Intranasal,
pubmed-meshheading:2907896-Adolescent,
pubmed-meshheading:2907896-Age Factors,
pubmed-meshheading:2907896-Child,
pubmed-meshheading:2907896-Child, Preschool,
pubmed-meshheading:2907896-Chorionic Gonadotropin,
pubmed-meshheading:2907896-Cryptorchidism,
pubmed-meshheading:2907896-Double-Blind Method,
pubmed-meshheading:2907896-Humans,
pubmed-meshheading:2907896-Infant,
pubmed-meshheading:2907896-Injections, Intramuscular,
pubmed-meshheading:2907896-Male,
pubmed-meshheading:2907896-Pituitary Hormone-Releasing Hormones,
pubmed-meshheading:2907896-Placebos,
pubmed-meshheading:2907896-Testis,
pubmed-meshheading:2907896-Time Factors
|
pubmed:year |
1988
|
pubmed:articleTitle |
Treatment of cryptorchidism with human chorionic gonadotropin or gonadotropin releasing hormone. A double-blind controlled study of 243 boys.
|
pubmed:affiliation |
University Department of Pediatrics, Hvidovre Hospital, Copenhagen, Denmark.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Controlled Clinical Trial,
Research Support, Non-U.S. Gov't
|